![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of B3GALT4 mRNA] | CTD | PMID:31150632 | (S)-amphetamine | decreases expression | EXP | | 6480464 | Dextroamphetamine results in decreased expression of B3GALT4 mRNA | CTD | PMID:16715494 | 1,2,4-trimethylbenzene | decreases expression | EXP | | 6480464 | pseudocumene results in decreased expression of B3GALT4 protein | CTD | PMID:17337753 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1343637 | 6480464 | Tetrachlorodibenzodioxin affects the expression of B3GALT4 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of B3GALT4 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731504 | 6480464 | Tetrachlorodibenzodioxin affects the expression of B3GALT4 mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of B3GALT4 mRNA | CTD | PMID:21346803 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1343637 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GALT4 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RGD:731504 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased methylation of B3GALT4 promoter | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:731504 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of B3GALT4 gene | CTD | PMID:31683443 | all-trans-retinoic acid | increases expression | ISO | RGD:1343637 | 6480464 | Tretinoin results in increased expression of B3GALT4 mRNA | CTD | PMID:23724009, PMID:33167477 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of B3GALT4 mRNA | CTD | PMID:16483693 | aristolochic acid A | increases expression | ISO | RGD:1343637 | 6480464 | aristolochic acid I results in increased expression of B3GALT4 mRNA | CTD | PMID:33212167 | benzalkonium chloride | affects response to substance | ISO | RGD:1343637 | 6480464 | B3GALT4 SNP affects the susceptibility to Benzalkonium Compounds | CTD | PMID:27258892 | benzo[a]pyrene | increases methylation | ISO | RGD:1343637 | 6480464 | Benzo(a)pyrene results in increased methylation of B3GALT4 exon, Benzo(a)pyrene results in increased methylation of B3GALT4 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | RGD:1343637 | 6480464 | bisphenol A results in decreased expression of B3GALT4 mRNA | CTD | PMID:25047013 | bisphenol A | increases expression | ISO | RGD:731504 | 6480464 | bisphenol A results in increased expression of B3GALT4 mRNA | CTD | PMID:32156529 | bisphenol A | increases methylation | ISO | RGD:1343637 | 6480464 | bisphenol A results in increased methylation of B3GALT4 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of B3GALT4 mRNA | CTD | PMID:34947998 | bisphenol A | multiple interactions | ISO | RGD:1343637 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of B3GALT4 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672, PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of B3GALT4 mRNA | CTD | PMID:30816183, PMID:32528016 | bisphenol F | multiple interactions | ISO | RGD:1343637 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672 | butanal | decreases expression | ISO | RGD:1343637 | 6480464 | butyraldehyde results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914, PMID:26079696 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of B3GALT4 promoter | CTD | PMID:22457795 | calcitriol | multiple interactions | ISO | RGD:1343637 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of B3GALT4 mRNA | CTD | PMID:21592394 | calcitriol | increases expression | ISO | RGD:1343637 | 6480464 | Calcitriol results in increased expression of B3GALT4 mRNA | CTD | PMID:21592394 | choline | multiple interactions | ISO | RGD:731504 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALT4 mRNA | CTD | PMID:20938992 | cisplatin | affects response to substance | ISO | RGD:1343637 | 6480464 | B3GALT4 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of B3GALT4 mRNA | CTD | PMID:24386269 | cypermethrin | increases expression | ISO | RGD:731504 | 6480464 | cypermethrin results in increased expression of B3GALT4 mRNA | CTD | PMID:29020013 | deoxynivalenol | decreases expression | ISO | RGD:1343637 | 6480464 | deoxynivalenol results in decreased expression of B3GALT4 mRNA | CTD | PMID:26763390 | dexamethasone | multiple interactions | ISO | RGD:1343637 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GALT4 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672 | folic acid | multiple interactions | ISO | RGD:731504 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALT4 mRNA | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | RGD:1343637 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of B3GALT4 gene | CTD | PMID:31601247 | heptanal | decreases expression | ISO | RGD:1343637 | 6480464 | heptanal results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914 | hexanal | decreases expression | ISO | RGD:1343637 | 6480464 | n-hexanal results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914 | indometacin | multiple interactions | ISO | RGD:1343637 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GALT4 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672 | L-methionine | multiple interactions | ISO | RGD:731504 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALT4 mRNA | CTD | PMID:20938992 | methamphetamine | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of B3GALT4 mRNA | CTD | PMID:19564919 | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of B3GALT4 mRNA | CTD | PMID:19564919 | naphthalenes | decreases expression | EXP | | 6480464 | Naphthalenes results in decreased expression of B3GALT4 protein | CTD | PMID:17337753 | nitrogen dioxide | multiple interactions | ISO | RGD:1343637 | 6480464 | [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of B3GALT4 gene | CTD | PMID:29935799 | octanal | decreases expression | ISO | RGD:1343637 | 6480464 | caprylic aldehyde results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914 | paracetamol | increases expression | ISO | RGD:1343637 | 6480464 | Acetaminophen results in increased expression of B3GALT4 mRNA | CTD | PMID:26690555 | pentanal | decreases expression | ISO | RGD:1343637 | 6480464 | pentanal results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914, PMID:26079696 | propanal | decreases expression | ISO | RGD:1343637 | 6480464 | propionaldehyde results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914, PMID:26079696 | SCH 23390 | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of B3GALT4 mRNA | CTD | PMID:19564919 | SCH 23390 | decreases expression | EXP | | 6480464 | SCH 23390 results in decreased expression of B3GALT4 mRNA | CTD | PMID:19564919 | silicon dioxide | decreases expression | ISO | RGD:1343637 | 6480464 | Silicon Dioxide analog results in decreased expression of B3GALT4 mRNA | CTD | PMID:25895662 | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of B3GALT4 mRNA | CTD | PMID:19281266 | succimer | multiple interactions | ISO | RGD:731504 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of B3GALT4 mRNA | CTD | PMID:21641980 | sulforaphane | decreases expression | ISO | RGD:1343637 | 6480464 | sulforaphane results in decreased expression of B3GALT4 mRNA | CTD | PMID:31838189 | sunitinib | decreases expression | ISO | RGD:1343637 | 6480464 | Sunitinib results in decreased expression of B3GALT4 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | ISO | RGD:1343637 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of B3GALT4 mRNA | CTD | PMID:21592394 | testosterone | increases expression | ISO | RGD:1343637 | 6480464 | Testosterone results in increased expression of B3GALT4 mRNA | CTD | PMID:21592394 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of B3GALT4 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of B3GALT4 mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of B3GALT4 mRNA | CTD | PMID:34492290 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of B3GALT4 mRNA | CTD | PMID:33387578 | tungsten | increases expression | ISO | RGD:731504 | 6480464 | Tungsten results in increased expression of B3GALT4 mRNA | CTD | PMID:30912803 | undecane | decreases expression | EXP | | 6480464 | undecane results in decreased expression of B3GALT4 protein | CTD | PMID:17337753 | valproic acid | increases methylation | ISO | RGD:1343637 | 6480464 | Valproic Acid results in increased methylation of B3GALT4 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:1343637 | 6480464 | Valproic Acid results in increased expression of B3GALT4 mRNA | CTD | PMID:23527032 | valproic acid | affects expression | ISO | RGD:1343637 | 6480464 | Valproic Acid affects the expression of B3GALT4 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1343637 | 6480464 | Valproic Acid results in decreased expression of B3GALT4 mRNA | CTD | PMID:29154799 | |